SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 28.06 |
| Enterprise Value ($M) | -40.80 |
| Book Value ($M) | 57.58 |
| Book Value / Share | 1.50 |
| Price / Book | 0.49 |
| NCAV ($M) | 53.34 |
| NCAV / Share | 1.39 |
| Price / NCAV | 0.53 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.85 |
| Return on Assets (ROA) | -0.59 |
| Return on Equity (ROE) | -0.71 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.95 |
| Current Ratio | 2.95 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 82.00 |
| Assets | 86.25 |
| Liabilities | 28.66 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Baker Bros. Advisors Lp | 0.00 | -100.00 | |
| 13G | BML Investment Partners, L.P. | 6.50 | ||
| 13D/A | Perceptive Advisors Llc | 14.20 | 0.38 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q/A (Amendment No. 1) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 221,481 | 517,041 | 42.84 | |
| 207,022 | 661,152 | 31.31 | |
| 1,029,848 | 3,481,874 | 29.58 | |
| 305,615 | 1,161,789 | 26.31 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ARVN – Arvinas, Inc. | ARWR – Arrowhead Pharmaceuticals, Inc. |
| ASMB – Assembly Biosciences, Inc. | ATRA – Atara Biotherapeutics, Inc. |
| AVIR – Atea Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io